JPH0532368B2 - - Google Patents

Info

Publication number
JPH0532368B2
JPH0532368B2 JP1500585A JP50058589A JPH0532368B2 JP H0532368 B2 JPH0532368 B2 JP H0532368B2 JP 1500585 A JP1500585 A JP 1500585A JP 50058589 A JP50058589 A JP 50058589A JP H0532368 B2 JPH0532368 B2 JP H0532368B2
Authority
JP
Japan
Prior art keywords
hdl
pharmaceutically acceptable
isomer
isomers
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP1500585A
Other languages
English (en)
Japanese (ja)
Other versions
JPH02503314A (ja
Inventor
Uiriamu Daroo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Schering Plough Corp
Original Assignee
Schering Plough Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Plough Corp filed Critical Schering Plough Corp
Publication of JPH02503314A publication Critical patent/JPH02503314A/ja
Publication of JPH0532368B2 publication Critical patent/JPH0532368B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP1500585A 1987-11-30 1988-11-28 ヒトの異常脂肪血症治療剤 Granted JPH02503314A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/126,441 US4788183A (en) 1987-11-30 1987-11-30 Method for treatment of dyslipidemia in humans
US126,441 1987-11-30

Publications (2)

Publication Number Publication Date
JPH02503314A JPH02503314A (ja) 1990-10-11
JPH0532368B2 true JPH0532368B2 (OSRAM) 1993-05-14

Family

ID=22424849

Family Applications (1)

Application Number Title Priority Date Filing Date
JP1500585A Granted JPH02503314A (ja) 1987-11-30 1988-11-28 ヒトの異常脂肪血症治療剤

Country Status (10)

Country Link
US (1) US4788183A (OSRAM)
EP (2) EP0318889A3 (OSRAM)
JP (1) JPH02503314A (OSRAM)
KR (1) KR890701111A (OSRAM)
AU (1) AU2816889A (OSRAM)
DK (1) DK132090D0 (OSRAM)
HU (1) HUT53526A (OSRAM)
NZ (1) NZ227123A (OSRAM)
WO (1) WO1989005146A2 (OSRAM)
ZA (1) ZA888993B (OSRAM)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5211947A (en) * 1988-12-16 1993-05-18 Schering Corporation Method for lowering blood cholesterol levels with granulocyte-macrophage colony stimulating factor
US6264960B1 (en) 1998-11-10 2001-07-24 Sander J. Robins Treatment of vascular events using lipid-modifying compositions
US20040072903A1 (en) * 2001-05-08 2004-04-15 Auerbach Bruce Jeffrey Carboxyalkylether-acat inhibitors combinations
WO2006020999A2 (en) * 2004-08-19 2006-02-23 The United States Of America, As Represented By The Secretary Of Agriculture Pterostilbene as a new agonist for the peroxisome proliferator-activated receptor alpha isoform

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4012444A (en) * 1969-07-08 1977-03-15 Allen & Hanburys Limited 5-[1-Hydroxy-2-(1-methyl-3-phenylpropyl)aminoethyl] salicylamide and physiologically acceptable acid addition salts thereof
ZA794872B (en) * 1978-09-20 1980-11-26 Schering Corp A phenylalkylaminoethylsalicylamide,its preparation and pharmaceutical compositions containing it
US4658060A (en) * 1982-04-26 1987-04-14 Schering Corporation Preparation of (-)-5-(beta)-1-hydroxy-2-((beta)-1-methyl-3-phenylpropyl)aminoethyl) salicylamide

Also Published As

Publication number Publication date
ZA888993B (en) 1989-07-26
AU2816889A (en) 1989-07-05
US4788183A (en) 1988-11-29
KR890701111A (ko) 1989-12-19
WO1989005146A3 (en) 1989-10-19
HU890492D0 (en) 1990-09-28
JPH02503314A (ja) 1990-10-11
EP0318889A2 (en) 1989-06-07
DK132090A (da) 1990-05-29
DK132090D0 (da) 1990-05-29
WO1989005146A2 (en) 1989-06-15
NZ227123A (en) 1990-08-28
EP0318889A3 (en) 1989-11-29
HUT53526A (en) 1990-11-28
EP0391958A1 (en) 1990-10-17

Similar Documents

Publication Publication Date Title
CA1322956C (en) Process for the production of dried earthworm powder and antihyperlipemic, antidiabetic, antihypertensive and antihypotensive preparations containing dried earthworm powder as active ingredient
CA2762013C (en) Granulation of pirfenidone and pharmaceutically acceptable excipients
JP2002537252A (ja) 心血管事象を予防するための必須脂肪酸
HU199302B (en) Process for producing synergic pharmaceutical compositions having hypotensive activity
KR20010093845A (ko) 피브레이트와 세리바스타틴의 복합제제
EP0546796A1 (en) Treatment of Atherosclerosis
CA2125822A1 (en) Therapeutic agent for alzheimer's disease
CZ147494A3 (en) Pharmaceutical preparation and process for preparing thereof
CN111635315B (zh) 一种解热镇痛药物及其制备方法和用途
JPH0532368B2 (OSRAM)
KR0180248B1 (ko) 항당뇨병약품
CA2112195A1 (en) Preventive and therapeutic agent for arteriosclerosis
JPH01186883A (ja) 抗アテローム性動脈硬化症剤としてのｄｌ‐５‐〔（２ベンジル‐３，４‐ジヒドロ‐２Ｈ‐ベンゾピラン‐６‐イル）メチル〕チアゾリジン‐２，４‐ジオン
JP2710633B2 (ja) 心臓疾患治療剤
US3932652A (en) Antidepressant compositions
EA009127B1 (ru) Комбинированное применение фибрата и орлистата для лечения ожирения
US4156003A (en) Treatment of hypertension with combination of clofibrinic acid or clofibrate with cinnarizine
US20030007959A1 (en) Oral methods of treatment
US5082846A (en) Use of the R-(+)-isomer of 2-methoxy-3-octadecyloxy-propanol-(1)-phosphoric acid, monocholine ester in treating multiple sclerosis
EP0555302A1 (en) Method of treating demyelinating disease
KR960014874B1 (ko) 요산 배출용 조성물
US3482016A (en) Method for treating fascioliasis
JPH02262519A (ja) 糖尿病性神経障害治療剤
KR950005869B1 (ko) 위염 치료제
JPH0526766B2 (OSRAM)